Serum asparaginase activity after a single dose of PEG-asparaginase (2500 IU/m2) given as a 1-hour intravenous infusion in children and adolescents with newly diagnosed ALL
Sample time, d . | No. of patients . | Serum asparaginase activity, IU/mL . | Percentage of patients with asparaginase activity, IU/mL . | |||
---|---|---|---|---|---|---|
Median (range) . | Mean ± SD . | ≥ 0.025 . | ≥ 0.1 . | ≥ 0.2 . | ||
4 | 130 | 0.66 (< 0.025-2.34) | 0.73 ± 0.29 | 96 | 96 | 96 |
11 | 133 | 0.48 (< 0.025-1.58) | 0.49 ± 0.22 | 97 | 95 | 92 |
18 | 112 | 0.20 (< 0.025-1.24) | 0.23 ± 0.14 | 96 | 88 | 52 |
25 | 113 | 0.04 (< 0.025-0.41) | 0.07 ± 0.05 | 70 | 7 | 2 |
Sample time, d . | No. of patients . | Serum asparaginase activity, IU/mL . | Percentage of patients with asparaginase activity, IU/mL . | |||
---|---|---|---|---|---|---|
Median (range) . | Mean ± SD . | ≥ 0.025 . | ≥ 0.1 . | ≥ 0.2 . | ||
4 | 130 | 0.66 (< 0.025-2.34) | 0.73 ± 0.29 | 96 | 96 | 96 |
11 | 133 | 0.48 (< 0.025-1.58) | 0.49 ± 0.22 | 97 | 95 | 92 |
18 | 112 | 0.20 (< 0.025-1.24) | 0.23 ± 0.14 | 96 | 88 | 52 |
25 | 113 | 0.04 (< 0.025-0.41) | 0.07 ± 0.05 | 70 | 7 | 2 |